Jay Schecter, MD
Neurology · Savannah, GANPI 1871658054
Payments from drug & device makers
Across 144 payments — averaging $23.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$1K
- Novartis$247
- AbbVie$199
- Sanofi$162
- Greenwich Biosciences, Inc.$140
- UCB, Inc.$136
- plus $2K from 29 others
What the payments were for
- Speaking & faculty fees$633%
- Food & beverage$2,35397%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 1 | $1,000 |
| Novartis | 17 | $247 |
| AbbVie(2 entities) | 13 | $199 |
| Sanofi | 8 | $162 |
| Greenwich Biosciences, Inc. | 4 | $140 |
| UCB, Inc. | 7 | $136 |
| GE HealthCare | 6 | $119 |
| Upsher-smith Laboratories LLC | 5 | $110 |
| Neurocrine Biosciences, Inc. | 8 | $97 |
| Amgen | 6 | $92 |
| Teva Pharmaceuticals USA, Inc. | 6 | $84 |
| Biogen | 6 | $77 |
| Merz North America, Inc. | 3 | $73 |
| AstraZeneca | 3 | $66 |
| Acorda Therapeutics, Inc | 3 | $63 |
| Bausch Health US, LLC | 3 | $62 |
| Supernus Pharmaceuticals, Inc. | 5 | $62 |
| Genentech USA, Inc. | 3 | $61 |
| EMD Serono, Inc. | 3 | $50 |
| Mallinckrodt Enterprises LLC | 3 | $47 |
| MDD US Operations, LLC | 3 | $45 |
| Lundbeck LLC | 2 | $45 |
| CSL Behring | 2 | $42 |
| Livanova USA, Inc. | 3 | $41 |
| Tersera Therapeutics LLC | 2 | $41 |
| Amneal Pharmaceuticals LLC | 3 | $39 |
| Acadia Pharmaceuticals Inc | 3 | $38 |
| Eisai Inc. | 2 | $37 |
| Lilly USA, LLC | 3 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Pfizer | 2 | $27 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
| Portola Pharmaceuticals, LLC | 1 | $11 |
How this compares
$3,416 in reported general payments places this provider in the 55th percentile of 506 neurology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Savannah
- Victor RosenfeldSavannah$413K
- Robert MacgregorSavannah$403K
- Jonathan LissColumbus$25M
- Marshall NashDecatur$13.6M
- James LahAtlanta$6.8M
- Jonathan GlassAtlanta$5.1M
- Sandeep VaidLawrenceville$4.2M
- Allan LeveyAtlanta$4.2M
- Ben ThrowerAtlanta$3.7M
- Jeffrey EnglishAtlanta$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.